FRANKLIN LAKES, N.J., July 7, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial release of a new ...

FRANKLIN LAKES, N.J., Sept. 27, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched BD® Research Cloud, a cloud-based ...

FRANKLIN LAKES, N.J. & ASHLAND, Ore.--(BUSINESS WIRE)--FlowJo, LLC, the provider of the market-leading third-party software for single cell analysis, and BD Life Sciences – Biosciences, a segment of ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the CE-IVD certification for the BD FACSDuet™ automated flow cytometry system. The new ...

FRANKLIN LAKES, N.J. & SAN DIEGO--(BUSINESS WIRE)-- BD (Becton, Dickinson and Company (BDX)), a leading global medical technology company, and Biosero, a developer of laboratory automation solutions ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced a collaboration with Biosero, a developer of laboratory automation solutions, to enable and facilitate robotic arm ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the ...

Labcorp is partnering with BD to develop flow cytometry-based companion diagnostics for diseases including cancer. The companies will collaborate with biopharmaceutical partners for exploratory panel ...

Medical technology company Becton, Dickinson and Co. is partnering with life sciences company Labcorp to develop cytometry-based companion diagnostics that can be used to match patients with ...